InvestorsHub Logo
Followers 56
Posts 5054
Boards Moderated 0
Alias Born 06/11/2007

Re: Alapis post# 102489

Thursday, 06/05/2014 10:08:45 AM

Thursday, June 05, 2014 10:08:45 AM

Post# of 130508
From Their 10Q Or K:

"We have not received, and do not expect to receive for at least the next several years in the case of Eltoprazine and MANF and until the 2 nd half of 2014 in the case of LymPro, if at all, any revenues from the commercialization of our product candidates."

Sooo we could hear something by this summer regarding Lympro right? And guesses here

And how positive is this for this stock?